Gilead Sciences, Inc. (GILD)

Gilead Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	6,311	480	5,613	4,566	6,201	89
Depreciation & Amortization	2,770	2,767	2,693	2,103	2,050	1,480
Stock-Based Compensation	872	835	766	637	635	643
Other Adjustments	-101	7,626	1,236	3,529	2,009	7,772
Change in Receivables	21	139	157	-406	313	-1,171
Changes in Inventories	-709	-426	-842	-310	11	-195
Changes in Accounts Payable	34	290	-347	226	-118	80
Changes in Accrued Expenses	47	108	458	-775	689	640
Changes in Income Taxes Payable	-1,205	-732	-1,768	-364	-361	-778
Changes in Other Operating Activities	-110	-259	39	-134	-45	-214
Operating Cash Flow	7,930	10,828	8,005	9,072	11,384	8,346
Operating Cash Flow Growth	59.05%	35.27%	-11.76%	-20.31%	36.40%	-8.73%
Capital Expenditures	-499	-523	-585	-728	-579	-650
Purchases of Investments	-85	-736	-2,372	-1,942	-3,897	-20,770
Proceeds from Sale of Investments	-	2,592	1,844	2,002	2,910	32,718
Payments for Business Acquisitions	-939	-4,840	-1,152	-1,797	-1,584	-25,920
Other Investing Activities	33	58	-1	-1	19	7
Investing Cash Flow	-3,466	-3,449	-2,265	-2,466	-3,131	-14,615
Long-Term Debt Issued	-	3,464	1,980	-	-	8,184
Long-Term Debt Repaid	-1,890	-1,970	-2,250	-1,500	-4,750	-2,500
Net Long-Term Debt Issued (Repaid)	-1,890	1,494	-270	-1,500	-4,750	5,684
Issuance of Common Stock	550	422	232	309	169	256
Repurchase of Common Stock	-1,907	-1,150	-1,000	-1,396	-546	-1,583
Net Common Stock Issued (Repurchased)	-1,357	-728	-768	-1,087	-377	-1,327
Common Dividends Paid	-3,960	-3,918	-3,809	-3,709	-3,605	-3,449
Other Financing Activities	-369	-281	-279	-173	-145	-138
Financing Cash Flow	-4,112	-3,433	-5,125	-6,469	-8,877	770
Effect of Exchange Rate Changes on Cash and Cash Equivalents	81	-40	57	-63	-35	43
Net Cash Flow	2,371	3,906	673	74	-659	-5,634
Beginning Cash & Cash Equivalents	2,772	6,085	5,412	5,338	5,997	11,631
Ending Cash & Cash Equivalents	5,144	9,991	6,085	5,412	5,338	5,997
Free Cash Flow	7,431	10,305	7,420	8,344	10,805	7,696
Free Cash Flow Growth	-27.89%	38.88%	-11.07%	-22.78%	40.40%	-7.49%
FCF Margin	25.88%	36.02%	27.55%	30.92%	40.01%	31.60%
Free Cash Flow Per Share	5.89	8.21	5.90	6.61	8.56	6.09
Levered Free Cash Flow	4,749	3,199	5,043	3,110	3,122	6,170
Unlevered Free Cash Flow	7,384	2,379	5,870	5,775	14,053	8,288

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q